Correlation Between 10X GENOMICS and COMPUGROUP MEDSPADR

Can any of the company-specific risk be diversified away by investing in both 10X GENOMICS and COMPUGROUP MEDSPADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X GENOMICS and COMPUGROUP MEDSPADR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 10X GENOMICS DL and COMPUGROUP MEDSPADR 1, you can compare the effects of market volatilities on 10X GENOMICS and COMPUGROUP MEDSPADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X GENOMICS with a short position of COMPUGROUP MEDSPADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X GENOMICS and COMPUGROUP MEDSPADR.

Diversification Opportunities for 10X GENOMICS and COMPUGROUP MEDSPADR

-0.21

Correlation Coefficient

10X GENOMICS  COMPUGROUP MEDSPADR

Very good diversification

The 3 months correlation between 10X and COMPUGROUP is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding 10X GENOMICS DL and COMPUGROUP MEDSPADR 1 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COMPUGROUP MEDSPADR and 10X GENOMICS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X GENOMICS DL are associated (or correlated) with COMPUGROUP MEDSPADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COMPUGROUP MEDSPADR has no effect on the direction of 10X GENOMICS i.e., 10X GENOMICS and COMPUGROUP MEDSPADR go up and down completely randomly.

Pair Corralation between 10X GENOMICS and COMPUGROUP MEDSPADR

Assuming the 90 days horizon 10X GENOMICS DL is expected to under-perform the COMPUGROUP MEDSPADR. But the stock apears to be less risky and, when comparing its historical volatility, 10X GENOMICS DL is 1.23 times less risky than COMPUGROUP MEDSPADR. The stock trades about -0.03 of its potential returns per unit of risk. The COMPUGROUP MEDSPADR 1 is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  3,641  in COMPUGROUP MEDSPADR 1 on October 12, 2024 and sell it today you would lose (1,441) from holding COMPUGROUP MEDSPADR 1 or give up 39.58% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

10X GENOMICS DL  vs.  COMPUGROUP MEDSPADR 1

10X GENOMICS DL

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in 10X GENOMICS DL are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, 10X GENOMICS may actually be approaching a critical reversion point that can send shares even higher in February 2025.

COMPUGROUP MEDSPADR

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in COMPUGROUP MEDSPADR 1 are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, COMPUGROUP MEDSPADR reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with 10X GENOMICS and COMPUGROUP MEDSPADR

The main advantage of trading using opposite 10X GENOMICS and COMPUGROUP MEDSPADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X GENOMICS position performs unexpectedly, COMPUGROUP MEDSPADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COMPUGROUP MEDSPADR will offset losses from the drop in COMPUGROUP MEDSPADR's long position.

The idea behind 10X GENOMICS DL and COMPUGROUP MEDSPADR 1 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.